8-K - Cue Biopharma, Inc. - 3.03 / 5.03
站内整理正文
Form 8-K - Current report: SEC Accession No. 0001193125-26-168907
Filing Date: 2026-04-22
Accepted: 2026-04-22 08:47:47
Documents: 10
Period of Report: 2026-04-22
Items: Item 3.03: Material Modifications to Rights of Security Holders Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Cue Biopharma, Inc. (Filer) CIK : 0001645460 (see all company filings) EIN. : 473324577 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-38327 | Film No.: 26881471 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)
1 | 8-K | cue-20260422.htm iXBRL | 8-K
2 | EX-3.1 | cue-ex3_1.htm | EX-3.1
3 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | cue-20260422.xsd | EX-101.SCH
13 | EXTRACTED XBRL INSTANCE DOCUMENT | cue-20260422_htm.xml | XML